Dr. Melissa Ann Herschman is a pharmacist who is specialized in Pharmacotherapy in Beachwood, Ohio. Patients can reach her at 4180 Warrensville Rd Bldg 5th, Beachwood or contact her on 216-491-7888. Active license number of Dr. Melissa Ann Herschman is 03233990 for Pharmacotherapy in Ohio. Dr. Melissa Ann Herschman is a licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing pharmacotherapeutic care of patients, by developing, implementing, monitoring, and modifying complex treatment plans, providing advanced level education and consultation, and collaborating with other health professionals in the management of therapy.
Complete Profile:
Dr. Melissa Ann Herschman speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Melissa Ann Herschman are as mentioned below.
NPI Number:
1396260345
NPI Enumeration Date:
11 Aug, 2017
NPI Last Update On:
11 Aug, 2017
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Melissa Ann Herschman are as mentioned below.
Specialization
License Number
State
Status
Pharmacotherapy
03233990
Ohio
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
20000 Harvard Ave, Warrensville Heights, Ohio
Zip:
44122-6805
Phone Number:
216-296-6515
Fax Number:
216-491-7167
Patients can reach Dr. Melissa Ann Herschman at 4180 Warrensville Rd Bldg 5th, Beachwood, Ohio or can call on phone at 216-491-7888.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.